The Analyst Verdict: GLOBALFOUNDRIES In The Eyes Of 6 Experts

Oct 8, 2024 · Ratings for GLOBALFOUNDRIES (NASDAQ:GFS) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below …

CouponFollow Extension

$68
OFF

The Analyst Landscape: 5 Takes On GLOBALFOUNDRIES

1 day from now

Jan 23, 2024 · In the assessment of 12-month price targets, analysts unveil insights for GLOBALFOUNDRIES, presenting an average target of $68.6, a high estimate of $75.00, and …

businessinsider.com

$87
OFF

The Analyst Verdict: Ambarella In The Eyes Of 4 Experts

1 day from now

17 hours ago · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $87.5, a high estimate of $100.00, and a low estimate …

benzinga.com

$49.65
OFF

The Analyst Verdict: Comcast In The Eyes Of 15 Experts

1 day from now

Nov 20, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $49.65, a high estimate of $60.00, and a low estimate of $40.00.

benzinga.com

$10
OFF

The Analyst Verdict: Vera Bradley In The Eyes Of 6 Experts

1 day from now

Jun 24, 2024 · Analysts have recently evaluated Vera Bradley and provided 12-month price targets. The average target is $10.0, accompanied by a high estimate of $10.00 and a low …

businessinsider.com

$43
OFF

The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts

1 day from now

Oct 16, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $43.5, a high estimate of $54.00, and a low estimate of $32.00.

nasdaq.com

$577.91
OFF

The Analyst Verdict: CACI International In The Eyes Of 11 Experts

1 day from now

Nov 12, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $577.91, with a high estimate of $650.00 and a low estimate …

nasdaq.com

$3.83
OFF

The Analyst Verdict: Thoughtworks Holding In The Eyes Of 6 Experts

1 day from now

Jul 12, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $3.83, a high estimate of $6.00, and a low estimate of $2.50.

nasdaq.com

FAQs about The Analyst Verdict: GLOBALFOUNDRIES In The Eyes Of 6 Experts Coupon?

What happened to GlobalFoundries?

GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 12,000 people. Financial Milestones: GLOBALFOUNDRIES's Journey ...

Who is GlobalFoundries?

About GLOBALFOUNDRIES GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. ...

How do analysts evaluate Globus Medical (GBM) stock?

Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Globus Medical compared to the broader market. Price Targets: Understanding forecasts, analysts offer estimates for Globus Medical's future value. ...

Do analysts make a good forecast?

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts. ...

What is a good Roe for GlobalFoundries?

With an ROE of 2.34%, the company may face hurdles in achieving optimal financial performance. Return on Assets (ROA): GLOBALFOUNDRIES's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.4%, the company may encounter challenges in delivering satisfactory returns from its assets. ...

What is GlobalFoundries's return on equity (ROE)?

Return on Equity (ROE): GLOBALFOUNDRIES's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.38%, the company may face hurdles in achieving optimal financial returns. ...